HELIX
LIVE

Serial Number

99140228

Owner

Helix, Inc.

Attorney

DEVIN LEE JOSEPH LOOIJEN

Filing Date

Apr 16, 2025

Add to watchlist:

No watchlists yet
View on USPTO

HELIX Trademark

Serial Number: 99140228

HELIX is a trademark filed by Helix, Inc. on April 16, 2025. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Helix, Inc.

400 S El Camino Real
San Mateo, CA 94402

Entity Type: 03

Trademark Details

Filing Date

April 16, 2025

Registration Date

Not Registered

Published for Opposition

September 16, 2025

Goods & Services

Non-downloadable electronic publications in the nature of reports and whitepapers in the field of artificial intelligence (AI); Providing online non-downloadable electronic publications in the nature of reports and whitepapers in the field of in the field of artificial intelligence (AI) relating to healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, precision medicine, and pharmacogenomics

Research in the field of artificial intelligence (AI); Platform as a service (PAAS) featuring computer software platforms relating to storing, managing, analyzing, sharing, distributing, referencing, monitoring and integrating genetic information using Artificial Intelligence (AI); Scientific research consultancy in the field of artificial intelligence (AI) for genetics; Providing a website featuring non-downloadable software using artificial intelligence (AI) for analyzing genomic data, providing clinicogenomic and genomic insights, processing bioinformatics information, supporting genomic data interpretation, and facilitating genomic information analysis in the fields of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, precision medicine, and pharmacogenomics; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for analyzing genomic data, providing clinicogenomic and genomic insights, processing bioinformatics information, supporting genomic data interpretation, and facilitating genomic information analysis in the fields of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, precision medicine, and pharmacogenomics; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for analyzing genomic data, providing clinicogenomic and genomic insights, processing bioinformatics information, supporting genomic data interpretation, and facilitating genomic information analysis in the fields of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, precision medicine, and pharmacogenomics; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for analyzing genomic data, providing clinicogenomic and genomic insights, processing bioinformatics information, supporting genomic data interpretation, and facilitating genomic information analysis the fields of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, precision medicine, and pharmacogenomics; Providing temporary use of online non-downloadable chatbot software using large language models (LLMs) for analyzing genomic data, providing clinicogenomic and genomic insights, processing bioinformatics information, supporting genomic data interpretation, and facilitating genomic information analysis in the fields of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, precision medicine, and pharmacogenomics; Providing temporary use of on-line non-downloadable cloud computing software using artificial intelligence (AI) for analyzing genomic data, providing clinicogenomic and genomic insights, processing bioinformatics information, supporting genomic data interpretation, and facilitating genomic information analysis in the fields of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, precision medicine, and pharmacogenomics

Promoting collaboration within the scientific, research and provider communities to achieve advances in the field of Artificial Intelligence (AI)

Downloadable electronic publications in the nature of reports and whitepapers in the field of artificial intelligence; Recorded computer programs using artificial intelligence (AI) for analyzing genomic data, providing clinicogenomic and genomic insights, processing bioinformatics information, supporting genomic data interpretation, and facilitating genomic information analysis in the fields of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, precision medicine, and pharmacogenomics; Downloadable chatbot software using large language models (LLMs) for analyzing genomic data, providing clinicogenomic and genomic insights, processing bioinformatics information, supporting genomic data interpretation, and facilitating genomic information analysis in the fields of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, precision medicine, and pharmacogenomics; Downloadable computer software using artificial intelligence (AI) for analyzing genomic data, providing clinicogenomic and genomic insights, processing bioinformatics information, supporting genomic data interpretation, and facilitating genomic information analysis in the fields of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, precision medicine, and pharmacogenomics

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 3, 2026 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jan 25, 2026 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Oct 16, 2025 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 16, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 16, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 10, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 18, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 15, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 15, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 15, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 15, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 31, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 31, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 31, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 1, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jul 1, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jul 1, 2025 CNRT
ASSIGNED TO EXAMINER
Jun 24, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 16, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 16, 2025 NWOS
NEW APPLICATION ENTERED
Apr 16, 2025 NWAP